Legal NewsRoom
Menu
Menu
LEGAL NEWS
HOT TOPICS
LexisNexis® Legal Newsroom
ACA and Healthcare Reform
Antitrust and Unfair Competition
Banking and Finance
Bankruptcy
California
Climate Change
Constitutional Law and Civil Rights
Consumer Protection & Privacy
Contracts and Commercial Law
Corporate
Criminal Law and Procedure
Energy
Environmental
Estate and Elder Law
Family Law
Financial Fraud Law
Florida
Fracking and Alternative Energy
Health Care
Hot Topics
Hurricane Sandy
Illinois
Immigration Law
Immigration Reform
Insurance Law
Intellectual Property
International Law
International Trade
Labor and Employment Law
Law360
Legal Business
Lexis® Hub
Litigation
Mealeys
Media and Entertainment
Mergers and Acquisitions
New Jersey
New York
Pennsylvania
Public Contracts
Public media
Public Policy
Real Estate Law
Securities
Sports Law
Tax Law
Technology
Texas
Top Emerging Trends
Torts
Virtual Currency
Workers' Compensation
NEWS & INSIGHT
Blogs and Newsletters
BIZ Blog
Blog Mosaic
Business of Law Blog
Corporate Law Advisory
Legal Content Insider
LexTalk
State Net
®
Capitol Journal
News & Trending Topics
Law360
Legal Insights & Trends
Lexis Practice Advisor Journal
Professional Communities
Business Insight Solutions – Partner Portal
Corporate InfoPro (Corporate Information Professionals)
InfoPro (Legal Information Professionals)
LexisNexis
®
for Developers
Litigators Verdict & Settlement Exchange
VISIT LEXISNEXIS LEGAL & PROFESSIONAL
Search
Search
Please enter a Keyword
This should not be used for legal research but instead can be used to find solutions that will help you do legal research.
Sign In
Browse By Tags
Alien Tort Statute
asbestos
breast cancer
drugs
FDA
hormone replacement therapy
HRT
Inc.
lawsuit
Litigation
meningitis
multidistrict litigation
Nigerians
off-label marketing
personal injury
Prempro
product liability
Settlement
Supreme Court
torts
Trovan
U.S. Supreme Court
United States of America v. Pfizer
verdict
Wyeth
Kevin M. LaCroix
over 12 years ago
Securities
Securities Law Blog
Pfizer's D&O Insurers Fund Unusual $75 Million Derivative Settlement
In the wake of Pfizer's record-setting September 2009 $2.3 billion settlement of charges that it had engaged in off-label marketing of Bextra and other drugs, Pfizer investors filed shareholders derivative lawsuits against the company, as nominal...
Tom Moylan
over 11 years ago
Top Emerging Trends
Emerging Issues Law Blog
2 Force $14.5 Million False Claims Act Settlement For Off-Label Marketing of Detrol
BOSTON - (Mealey's) Two whistle-blowers who went it alone in prosecuting a False Claims Act lawsuit against Pfizer Inc. in a Massachusetts federal court have forced a $14.5 million settlement for the off-label marketing of Detrol, according to announcements...
Tom Moylan
over 12 years ago
Top Emerging Trends
Emerging Issues Law Blog
Pfizer Petition for Certiorari Denied by U.S. Supreme Court In Trovan Nigerian Clinical Trial Case
WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on June 29 rejected Pfizer Inc.'s petition for a writ of certiorari involving the claims of Nigerians allegedly injured during a 1996 Trovan clinical trial in their country, allowing the claims...
Tom Moylan
over 7 years ago
Litigation
Litigation Blog
Defense Verdict Returned In Purported 1st Zoloft Birth Defect Trial
ST. LOUIS — (Mealey’s) A Missouri state court jury on April 17 returned a defense verdict in a Zoloft birth defect trial said by the parties to be the first trial of its kind in the nation ( Kristyn Pesante, et al. v. Pfizer, Inc. , No. 122...
Cheryl Keely
over 12 years ago
Litigation
Litigation Blog
Judge Denies Quigley Company's Plan Of Reorganization
NEW YORK - (Mealey's) Finding that Pfizer Inc. manipulated creditor votes in seeking support for a plan of reorganization for its wholly owned subsidiary Quigley Co. Inc., a New York bankruptcy judge on Sept. 8 denied Quigley's plan of reorganization...
Emerson Heffner
over 10 years ago
Litigation
Litigation Blog
Asbestos Claims Against Quigley Parent Pfizer Allowed By 2nd Circuit
NEW YORK - (Mealey's) Personal injury suits seeking to hold Pfizer Inc. liable for asbestos-containing products manufactured by bankrupt subsidiary Quigley Co. Inc. under an "apparent manufacturer" theory of liability are not barred by an...
Emerson Heffner
over 9 years ago
Litigation
Litigation Blog
Pfizer Faces Asbestos Actions After Supreme Court Declines To Hear Case
WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on June 24 denied a bid for certiorari by Pfizer Inc. of a ruling removing the protection for Pfizer of a bankruptcy injunction barring asbestos personal injury claims entered in the case of a defunct...
Michael Lefkowitz
over 12 years ago
Litigation
Litigation Blog
Federal Judge Dismisses Consumer Lawsuit Over Pfizer Drugs
PHILADELPHIA - (Mealey's) A federal judge in Pennsylvania on July 20 dismissed a putative consumer class action that alleged fraudulent marketing of 12 Pfizer Inc. drugs, saying that the plaintiffs failed to demonstrate an injury or reliance upon...
Tom Moylan
over 10 years ago
Litigation
Litigation Blog
Connecticut Federal Jury Finds Warning Adequate In Prempro Wrongful Death Suit
BRIDGEPORT, Conn. - (Mealey's) Wyeth is not liable for the breast cancer death of a woman who took the company's hormone therapy drugs Premarin and Prempro, a Connecticut federal jury said May 30, finding that the drugs' labeling contained...
Shane Dilworth
over 12 years ago
Litigation
Litigation Blog
Supreme Court Denies Wyeth's Petition For Certiorari Over Punitive Damages Trial
WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on June 21 denied Wyeth's petition for a writ of certiorari seeking reversal of the Eighth Circuit U.S. Court of Appeals ruling allowing a punitive-damages-only trial for a woman claiming that...
Tom Moylan
over 11 years ago
Litigation
Litigation Blog
Pennsylvania Jury Awards $72.6 Million To 3 Women In HRT Breast Cancer Case
PHILADELPHIA - (Mealey's) A Pennsylvania state court jury on Dec. 6 awarded $72.6 million to three women who say they developed breast cancer after taking hormone replacement therapy (HRT) drugs made by subsidiaries of Pfizer Inc. ( Susan Elfont,...
Tom Moylan
over 10 years ago
Litigation
Litigation Blog
Zoloft Birth Defects MDL Created, Assigned To Eastern District Of Pennsylvania
WASHINGTON, D.C. - (Mealey's) More than 92 federal lawsuits alleging birth defects caused by the antidepressant Zoloft and its generic version sertraline were centralized April 17 before Judge Cynthia M. Rufe in the U.S. District Court for the Eastern...
Tom Moylan
over 8 years ago
Litigation
Litigation Blog
Pfizer To Pay $325M To Settle Neurontin 3rd-Party Payer, Antitrust Class Action
BOSTON — (Mealey’s) Pfizer Inc. has agreed to a $325 million class settlement of claims by third-party payers that allege that the off-label promotion of the epilepsy drug Neurontin violated the Racketeer Influenced and Corrupt Organizations...
Tom Moylan
over 10 years ago
Litigation
Litigation Blog
$4 Million In Compensatory Damages Awarded By Connecticut Jury In Prempro Breast Cancer Trial
NEW HAVEN, Conn. - (Mealey's) A Connecticut federal jury on April 18 awarded a plaintiff and her husband $4 million in compensatory damages after finding that the hormone replacement therapy drug Prempro caused the plaintiff's breast cancer (...
Tom Moylan
over 12 years ago
Litigation
Litigation Blog
2nd Circuit Sends N.J. Whistle-Blower Claims Of Ex-Pfizer Executive Back For Reconsideration
NEW YORK -- (Mealey's) A Second Circuit U.S. Court of Appeals panel on Nov. 17 affirmed summary judgment on federal False Claims Act (FCA) termination claims by former Pfizer executive Peter Rost but reversed judgment as to his claims under New Jersey's...
>